
Digital Solution Provider

2023 China Healthcare Trend Development Summit was recently held in Shanghai. At the summit, MedTrend, Med+ Research Institute, and Shanghai Health Development Research Center jointly releasedThe First "List of China and Global Competitiveness and Investment Value of Big Health Enterprises": GE Healthcare Tops the "Multinational Enterprises' Competitiveness in China" in the Medical Device Field with a China Competitiveness Index of 65.7, and Ranks First in the "Revenue and Pipeline Sub-lists" as "China Pipeline Speed NO.1", Becoming a Leader in Exploring a New Path of Chinese-style Development for Multinational Enterprises.。


The list conducts a comprehensive evaluation of multiple large healthcare multinational enterprises through 36 indicators across five major fields: revenue, pipeline, business development, talent, and brand, benchmarking the true value of the industry to discover and encourage healthcare companies genuinely committed to innovation in China and expanding healthcare accessibility.GE Healthcare Tops the List with Its Expanding Comprehensive 'Made in China' Layout, Growing Influence, and Contributions in China。

GE Healthcare Global Executive Vice President, China President and CEO Zhang Yihao Takes the Stage for the Third Consecutive Year at the "2023 Healthcare Trend Development Forum" to Deliver a Keynote Speech Titled "Embarking on a New Path of Localized Innovation."
He emphasized in his speech:
"Over the past decade, the market share of imaging equipment produced in China has been increasing year by year, growing from 37% in 2012 to 68% in 2022. The export value of medical devices has increased 1.9 times over the past 10 years*. GE Healthcare still firmly believes that 'the next China is still China.' Based on this, we have observed that,Not only should it be made in China, but also fully made in China, building a 'win-win chain' for high-end medical devices; not only should there be innovation, but also boundless innovation to fully unleash China's scientific and technological potential for the benefit of all; not only should there be cooperation, but also win-win cooperation—deepening international collaboration and promoting a common destiny for humanity is the righteous path.。”
*Data source: "Market Insights Report on China-Produced Medical Devices in China (2023)"


